Back to Agenda
Session 5 - Clinical Data Management Principles
Session Chair(s)
Manami Hashimoto
Manager, Oncology Data Mgt Gr, Integrated Science & Operations Dept,Oncology Div
Novartis Pharma K.K., Japan
Tomoko Sugiyama
Associate Manager, Data Practice Group, Biomedical Data Sciences Department
GlaxoSmithKline K.K., Japan
Clinical Data Management (CDM) has been evolving and developing their expertise in computerization and globalization by optimizing and standardizing our ever more complicated work. Principles of CDM have also been changing. We would like to make this session a chance to re-discover and re-educate the fundamental principle of CDM’s role and ensuring clinical data reliability. Thinking through the fundamental principle, we hope to discuss what we should do for the future evolution of CDM.
Speaker(s)
Advancing Data Management in Academic Research Organizations
Reza Rostami, MBA, RAC
Duke Clinical Research Institute, United States
Associate Director, Quality Management
DM Principles from JPMA
Osamu Komiyama
Pfizer R&D Japan G.K., Japan
Senior Manager, Statistical Research & Data Science
Is CDM in ARO, CRO, Sponsor Different?
Makoto Yokobori
SUXAC Inc., Japan
President
Toshihiko Watanabe
Japan CRO Association, Japan
Advisor
Yuu Jincho, JD, MSc
GlaxoSmithKline K.K., Japan
Manager, Data Practice Group, Biomedical Data Sciences Dept., RD Japan
Have an account?